Evofem Biosciences, Inc.EVFMOTCMARKET
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank36
Year-over-Year Change
Year-over-year gross profit growth rate
Percentile
P36
Within normal range
vs 2Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -2.53% |
| Q2 2025 | 747.92% |
| Q1 2025 | -91.42% |
| Q4 2024 | 54.18% |
| Q3 2024 | 6.96% |
| Q2 2024 | 16.17% |
| Q1 2024 | -24.86% |
| Q4 2023 | 23.92% |
| Q3 2023 | 540.31% |
| Q2 2023 | -119.33% |
| Q1 2023 | 354.07% |
| Q4 2022 | -132.65% |
| Q3 2022 | -3.31% |
| Q2 2022 | 81.90% |
| Q1 2022 | 117.48% |
| Q4 2021 | 793.08% |
| Q3 2021 | -67.25% |
| Q2 2021 | 436.49% |
| Q1 2021 | 116.78% |
| Q4 2020 | -60.36% |
| Q3 2020 | -8.27% |
| Q2 2020 | -9.01% |
| Q1 2020 | -5.91% |
| Q4 2019 | -233.33% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | -1.54% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | -221.50% |
| Q4 2017 | -189.08% |
| Q3 2017 | 0.01% |
| Q2 2017 | 40.02% |
| Q1 2017 | 23.45% |
| Q4 2016 | 17.35% |
| Q3 2016 | 0.00% |